Catalyst Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Catalyst Capital Advisors LLC

$4.41 Billion
Q3 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 9,770 shares of VRTX stock, worth $4.01 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

9,770

Previous 10,095 3.22%

Holding current value

$4.01 Million

Previous $4.73 Million 3.97%

% of portfolio

0.1%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$460.0 - $505.78 $149,500 - $164,378	-325 Reduced 3.22%	9,770 $4.54 Million
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $18,854 - $23,305	-48 Reduced 0.47%	10,095 $4.73 Million
Q1 2024 Apr 24, 2024	SELL	$407.69 - $446.08 $70,938 - $77,617	-174 Reduced 1.69%	10,143 $4.24 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $273,714 - $327,722	-798 Reduced 7.18%	10,317 $4.2 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $110,584 - $118,524	-327 Reduced 2.86%	11,115 $3.87 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $190,224 - $212,905	-605 Reduced 5.02%	11,442 $4.03 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $289,461 - $330,208	1,022 Added 9.27%	12,047 $3.8 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $3.09 Million - $3.48 Million	10,820 Added 5278.05%	11,025 $3.18 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $547 - $611	2 Added 0.99%	205 $59,000
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $6,578 - $8,191	28 Added 16.0%	203 $57,000
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $6,864 - $8,090	31 Added 21.53%	175 $46,000
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $2,124 - $2,681	-12 Reduced 7.69%	144 $32,000
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $544 - $608	-3 Reduced 1.89%	156 $28,000
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $937 - $1,105	5 Added 3.25%	159 $32,000
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $6,003 - $6,997	-29 Reduced 15.85%	154 $33,000
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $5.93 Million - $7.91 Million	-28,667 Reduced 99.37%	183 $43,000
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $472,952 - $560,735	-1,850 Reduced 6.03%	28,850 $7.85 Million
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $631,344 - $828,240	-2,800 Reduced 8.36%	30,700 $8.91 Million
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $6.69 Million - $8.3 Million	33,500 New	33,500 $7.97 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History